BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15101968)

  • 1. Topical ketamine gel: possible role in treating neuropathic pain.
    Gammaitoni A; Gallagher RM; Welz-Bosna M
    Pain Med; 2000 Mar; 1(1):97-100. PubMed ID: 15101968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiologic basis of the treatment of neurogenic pain].
    Planjar-Prvan M; Bielen I; Baraba R; Buljan R
    Acta Med Croatica; 2004; 58(3):197-205. PubMed ID: 15503683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapy for neuropathic pain.
    Mizoguchi H; Watanabe C; Yonezawa A; Sakurada S
    Int Rev Neurobiol; 2009; 85():249-60. PubMed ID: 19607975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
    Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
    Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ketamine in pain management.
    Visser E; Schug SA
    Biomed Pharmacother; 2006 Aug; 60(7):341-8. PubMed ID: 16854557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for neuropathic pain.
    Jackson KC
    Pain Pract; 2006 Mar; 6(1):27-33. PubMed ID: 17309706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
    Ong EC
    Oncology; 2008; 74 Suppl 1():72-5. PubMed ID: 18758202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer.
    Goodchild CS; Nelson J; Cooke I; Ashby M; Jackson K
    Pain Med; 2008 Oct; 9(7):939-49. PubMed ID: 18950447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients.
    Kiefer RT; Rohr P; Ploppa A; Nohé B; Dieterich HJ; Grothusen J; Altemeyer KH; Unertl K; Schwartzman RJ
    Pain Med; 2008; 9(1):44-54. PubMed ID: 18254766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain.
    Cohen SP; Wang S; Chen L; Kurihara C; McKnight G; Marcuson M; Mao J
    J Pain Symptom Manage; 2009 Apr; 37(4):698-708. PubMed ID: 18789637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain.
    Lefaucheur JP; Drouot X; Cunin P; Bruckert R; Lepetit H; Créange A; Wolkenstein P; Maison P; Keravel Y; Nguyen JP
    Brain; 2009 Jun; 132(Pt 6):1463-71. PubMed ID: 19336459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
    Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of ketamine in the long-term treatment of neuropathic pain.
    Cvrcek P
    Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia.
    Zakrzewska JM
    Evid Based Dent; 2007; 8(3):85-6. PubMed ID: 17891129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouting phenomenon, a new model for the role of A-beta fibers in wind up.
    Hoseini SS; Hoseini M; Gharibzadeh S
    Med Hypotheses; 2006; 66(4):805-7. PubMed ID: 16356653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative ketamine does not prevent chronic pain after thoracotomy.
    Dualé C; Sibaud F; Guastella V; Vallet L; Gimbert YA; Taheri H; Filaire M; Schoeffler P; Dubray C
    Eur J Pain; 2009 May; 13(5):497-505. PubMed ID: 18783971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.